Health Care: Drugs

Rigel Pharmaceuticals Inc (RIGL: NASDAQ)

$2.37 -0.07 | -2.87%
12/22/14 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 2.44
52 Week High 5.00
52 Week Low 1.56
Avg. Daily Vol. (Mil) 0.57
Beta (3 year) 1.95
Share Related Items
Mkt Cap (Mil) 214.21
Shares Out (Mil) 87.79
Float (Mil) 78.26
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 15.50
Current Ratio 15.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 37.25
Price/Book 1.46
Price/Cash Flow -2.60
Per Share Data
Earnings -0.98
Sales 0.07
Book Value 1.67
Cash Flow -0.95
Business Summary
Rigel Pharmaceuticals Inc is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases, as well as for certain cancers and metabolic diseases.
General Information
1180 Veterans Boulevard
South San Francisc, CA 94080
www.rigel.com
Industry : Drugs
Sector: Health Care
Employees: 129
CEO: Raul R. Rodriguez
Short Interest
Current Month (Mil) 2.57
Previous Month (Mil) 2.37
Short Interest Ratio (Days) 5.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -52.40
Return on Investments -58.20
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00

Portfolios with RIGL

Latest RIGL Headlines from TheStreet

More Financial News for RIGL

Press Releases for RIGL

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter